The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Irish Pharmaceutical Healthcare Association naming Muiris O’Connor .

Filed returns
14
match these filters
Matching filed returns per period 0 1 2 3 5 Jan–Apr 2019: 2 filed returns Sep–Dec 2020: 1 filed returns Jan–Apr 2021: 2 filed returns May–Aug 2021: 1 filed returns May–Aug 2024: 1 filed returns Sep–Dec 2024: 1 filed returns Jan–Apr 2025: 2 filed returns Jan–Apr 2026: 3 filed returns May–Aug 2026: 1 filed returns 2019 2021 2025 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
May–Aug 2026 Irish Pharmaceutical Healthcare Association Health Industry perspectives on access, innovation and coordination. (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2026 Irish Pharmaceutical Healthcare Association Health Medicines Shortage - Provision in proposed EU General Pharmaceutical Legislation regarding medicines shortages prevention plan. (Legislation) 1 On lobbying.ie
Jan–Apr 2026 Irish Pharmaceutical Healthcare Association Health Industry position on a National Life Sciences Strategy (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2026 Irish Pharmaceutical Healthcare Association Health (i) IPHA priorities for EU Presidency and (ii) EU Presidency Events (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2025 Irish Pharmaceutical Healthcare Association Health Proposed revision of EU General Pharmaceutical Legislation and Irish Government position on access to medicines in EU smaller countries/markets and intellectual property rights. (Public policy or programme) 3 On lobbying.ie
Jan–Apr 2025 Irish Pharmaceutical Healthcare Association Health Issues concerning the timely reimbursement of medicines in Ireland. (Public policy or programme) 12 On lobbying.ie
Sep–Dec 2024 Irish Pharmaceutical Healthcare Association Health EU Commission proposed revision of the EU General Pharmaceutical Legislation and related matters, with particular attention to intellectual property rights provisions, competitiveness and regulatory affairs. (Legislation) 8 On lobbying.ie
May–Aug 2024 Irish Pharmaceutical Healthcare Association Health (i) Proposed revision of EU General Pharmaceutical Legislation, particularly items relating to incentives/intellectual property rights; (ii) EU wide access to new medicines. (Legislation) 10 On lobbying.ie
May–Aug 2021 Irish Pharmaceutical Healthcare Association Health WTO TRIPS Waiver of IP rights (Public policy or programme) 4 On lobbying.ie
Jan–Apr 2021 Irish Pharmaceutical Healthcare Association Health Report on Value of Expenditure on Medicines (Matters involving public funds) 4 On lobbying.ie
Jan–Apr 2021 Irish Pharmaceutical Healthcare Association Health EU Pharmaceutical Strategy (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2020 Irish Pharmaceutical Healthcare Association Health Readiness of Ireland to produce and provide cell and gene therapies (Matters involving public funds) 1 On lobbying.ie
Jan–Apr 2019 Irish Pharmaceutical Healthcare Association Health To highlight importance of continuity of supply of medicines in Europe post Brexit (Public policy or programme) 5 On lobbying.ie
Jan–Apr 2019 Irish Pharmaceutical Healthcare Association Health Originator pharmaceutical industry's preparations for Brexit (Public policy or programme) 9 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 14 100.0%